Výsledky vyhledávání - Gavin Marx
- Zobrazuji výsledky 1 - 20 z 22
- Přejít na další stránku
-
1
-
2
-
3
-
4
Phase 2 study of circulating microRNA biomarkers in castration-resistant prostate cancer Autor Hui‐Ming Lin, Kate Mahon, Calan Spielman, Howard Gurney, Girish Mallesara, Martin R. Stockler, Patricia Bastick, Karen Briscoe, Gavin Marx, Alexander Swarbrick, Lisa G. Horvath
Vydáno 2017Artigo -
5
Denosumab and Bone Metastasis–Free Survival in Men With Nonmetastatic Castration-Resistant Prostate Cancer: Exploratory Analyses by Baseline Prostate-Specific Antigen Doubling Time... Autor Matthew R. Smith, Fred Saad, Stéphane Oudard, Neal D. Shore, Karim Fizazi, Paul Sieber, Bertrand Tombal, Ronaldo Damião, Gavin Marx, Kurt Miller, Peter J. Van Veldhuizen, Juan Moróte, Zhishen Ye, Roger Dansey, Carsten Goessl
Vydáno 2013Artigo -
6
Identification of Candidate Biomarkers of Therapeutic Response to Docetaxel by Proteomic Profiling Autor Liangli Zhao, Brian Y. Lee, David A. Brown, Mark P. Molloy, Gavin Marx, Nick Pavlakis, Michael Boyer, Martin R. Stockler, Warren Kaplan, Samuel N. Breit, Robert L. Sutherland, Susan M. Henshall, Lisa G. Horvath
Vydáno 2009Artigo -
7
Methylated Glutathione S-transferase 1 (mGSTP1) is a potential plasma free DNA epigenetic marker of prognosis and response to chemotherapy in castrate-resistant prostate cancer Autor Kate Mahon, W Qu, James Devaney, Cheryl Paul, Lesley Castillo, Richard Wykes, Mark D. Chatfield, Michael Boyer, Martin R. Stockler, Gavin Marx, Howard Gurney, Girish Mallesara, Peter L. Molloy, Lisa G. Horvath, Susan J. Clark
Vydáno 2014Artigo -
8
Pain and analgesic use associated with skeletal-related events in patients with advanced cancer and bone metastases Autor Roger von Moos, Jean-Jacques Body, Blair Egerdie, Alison Stopeck, Janet E. Brown, Lesley Fallowfield, Donald L. Patrick, Charles S. Cleeland, Danail Damyanov, Felipe Salvador Palazzo, Gavin Marx, Ying Zhou, Ada Braun, Arun Balakumaran, Yi Qian
Vydáno 2015Artigo -
9
Circulating microRNAs are associated with docetaxel chemotherapy outcome in castration-resistant prostate cancer Autor Hui‐Ming Lin, Lesley Castillo, Kate Mahon, Keng Hoong Chiam, B Y Lee, Quoc Nguyen, Michael Boyer, Martin R. Stockler, Nick Pavlakis, Gavin Marx, Girish Mallesara, Howard Gurney, Susan J. Clark, Alexander Swarbrick, Roger J. Daly, Lisa G. Horvath
Vydáno 2014Artigo -
10
A distinct plasma lipid signature associated with poor prognosis in castration‐resistant prostate cancer Autor Hui‐Ming Lin, Kate Mahon, Jacquelyn M. Weir, Piyushkumar A. Mundra, Calan Spielman, Karen Briscoe, Howard Gurney, Girish Mallesara, Gavin Marx, Martin R. Stockler, PRIMe Consortium, Robert G. Parton, Andrew J. Hoy, Roger J. Daly, Peter J. Meikle, Lisa G. Horvath
Vydáno 2017Artigo -
11
Cytokine profiling of docetaxel-resistant castration-resistant prostate cancer Autor Kate Mahon, H-M Lin, Lesley Castillo, B Y Lee, Michelle Lee-Ng, Mark D. Chatfield, Karen Chiam, Samuel N. Breit, David A. Brown, Mark P. Molloy, Gavin Marx, Nick Pavlakis, Michael Boyer, Martin R. Stockler, Roger J. Daly, Susan M. Henshall, Lisa G. Horvath
Vydáno 2015Artigo -
12
Validity of Patient-Reported Outcome Measures in Evaluating Nerve Damage Following Chemotherapy Autor Tiffany Li, Hannah C. Timmins, Fawaz Mayez Mahfouz, Terry Trinh, David Mizrahi, Lisa G. Horvath, Michelle Harrison, Peter Grimison, Michael Friedlander, Gavin Marx, Frances Boyle, David Wyld, Robert D. Henderson, Tracy King, Sally Baron‐Hay, Matthew C. Kiernan, Claudia Rutherford, David Goldstein, Susanna B. Park
Vydáno 2024Artigo -
13
Cabozantinib Versus Mitoxantrone-prednisone in Symptomatic Metastatic Castration-resistant Prostate Cancer: A Randomized Phase 3 Trial with a Primary Pain Endpoint Autor Ethan Basch, Mark C. Scholz, Johann S. de Bono, Nicholas J. Vogelzang, Paul de Souza, Gavin Marx, Ulka N. Vaishampayan, Saby George, James K. Schwarz, Emmanuel S. Antonarakis, Joe M. O’Sullivan, Arash Rezazadeh Kalebasty, Kim N., Robert Dreicer, Thomas E. Hutson, Amylou C. Dueck, Antonia V. Bennett, Erica Simone Dayan, Milan Mangeshkar, Jaymes Holland, Aaron Weitzman, Howard I. Scher
Vydáno 2018Artigo -
14
Enzalutamide with standard first-line therapy for metastatic hormone-sensitive prostate cancer: a plain language summary of the ENZAMET trial (ANZUP 1304) Autor Ciara Conduit, Andrisha–Jade Inderjeeth, R.J. Allen, Andrew Martin, Wendy R. Parulekar, Eibhlin Mulroe, Margaret McJannett, Robert Zielinski, Alastair Thomson, Thean Hsiang Tan, Shahneen Sandhu, M. Neil Reaume, David Pook, Scott North, Gavin Marx, Anthony M. Joshua, Lisa G. Horvath, Ray McDermott, Simon Chowdhury, Kim N., Alison Y. Zhang, Martin R. Stockler, Ian D. Davis, Christopher J. Sweeney
Vydáno 2025Artigo -
15
Overcoming enzalutamide resistance in metastatic prostate cancer by targeting sphingosine kinase Autor Hui‐Ming Lin, Blossom Mak, Nicole Yeung, Kevin Huynh, Thomas G. Meikle, Natalie A. Mellett, Edmond M. Kwan, Heidi Fettke, Ben Tran, Ian D. Davis, Kate Mahon, Alison Y. Zhang, Martin R. Stockler, Karen Briscoe, Gavin Marx, Megan Crumbaker, Phillip D. Stricker, Pan Du, Jianjun Yu, Shidong Jia, Tahlia Scheinberg, Michael Fitzpatrick, P.D. Bonnitcha, David Sullivan, Anthony M. Joshua, Arun Azad, Lisa M. Butler, Peter J. Meikle, Lisa G. Horvath
Vydáno 2021Artigo -
16
Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer Autor Ian D. Davis, Andrew Martin, Martin R. Stockler, Stephen Begbie, Kim N., Simon Chowdhury, Xanthi Coskinas, Mark Frydenberg, Wendy Hague, Lisa G. Horvath, Anthony M. Joshua, Nicola Jane Lawrence, Gavin Marx, John McCaffrey, Ray McDermott, Margaret McJannett, Scott North, Francis Parnis, Wendy R. Parulekar, David Pook, M. Neil Reaume, Shahneen Sandhu, Alvin Tan, Thean Hsiang Tan, Alastair Thomson, Emily Tu, Francisco Vera-Badillo, Scott Williams, Sonia Yip, Alison Y. Zhang, Robert Zielinski, Christopher J. Sweeney
Vydáno 2019Artigo -
17
Preoperative cisplatin, fluorouracil, and docetaxel with or without radiotherapy after poor early response to cisplatin and fluorouracil for resectable oesophageal adenocarcinoma (... Autor Andrew P. Barbour, Euan Walpole, Gang Mai, Elizabeth H Barnes, David I. Watson, Stephen P. Ackland, Jennifer Martin, Matthew Burge, Robert J. Finch, Christos S. Karapetis, J. Shannon, Louise Nott, Suresh Varma, Gavin Marx, Gregory L. Falk, Val Gebski, Martinus Oostendorp, Kate Wilson, Janine Thomas, Guy Lampe, John Zalcberg, John Simes, B. Mark Smithers, Andrew P. Barbour, John Simes, Euan Walpole, T. Mai, David I. Watson, Christos S. Karapetis, Val Gebski, Larisa Ariadne Justine Barnes, Martinus Oostendorp, Kate Wilson
Vydáno 2020Artigo -
18
Health-Related Quality of Life in Metastatic, Hormone-Sensitive Prostate Cancer: ENZAMET (ANZUP 1304), an International, Randomized Phase III Trial Led by ANZUP Autor Martin R. Stockler, Andrew Martin, Ian D. Davis, Haryana M. Dhillon, Stephen Begbie, Kim N., Simon Chowdhury, Xanthi Coskinas, Mark Frydenberg, Wendy Hague, Lisa G. Horvath, Anthony M. Joshua, Nicola Jane Lawrence, Gavin Marx, John McCaffrey, Ray McDermott, Margaret McJannett, Scott North, Francis Parnis, Wendy R. Parulekar, David Pook, M. Neil Reaume, Shahneen Sandhu, Alvin Tan, Thean Hsiang Tan, Alastair Thomson, Francisco Vera-Badillo, Scott Williams, Diana Winter, Sonia Yip, Alison Y. Zhang, Robert Zielinski, Christopher J. Sweeney
Vydáno 2021Artigo -
19
Improved tolerability of neratinib in patients with HER2-positive early-stage breast cancer: the CONTROL trial Autor CH Barcenas, Sara A. Hurvitz, Jack A. Di Palma, Ron Bose, A. Jo Chien, Nicholas Iannotti, Gavin Marx, Adam Brufsky, Anya M. Litvak, Elsayed Ibrahim, Ricardo H. Álvarez, Manuel Ruíz‐Borrego, Nancy Chan, Yvonne Manalo, A. Kellum, Maureen Trudeau, Michael P. Thirlwell, J. García Saenz, Daniel Hunt, Richard Bryce, Leanne McCulloch, Hope S. Rugo, Debu Tripathy, Arlene Chan, Lauren Carcas, Aurelio Castrellon, Derwin King Chung Chan, K. Cheong, Byung Ock Choi, Michel P. Coleman, Alison Conlin, Robert Dichmann, David H. Ellison, Nicholette Erickson, Ira Gore, Vincent Hansen, D B Huang, David Hufnagel, Frederic Kass, Stephan D. Kendall, Mark Kozloff, W Lawler, Kelly D. Nahum, Barbara Pistilli, Eduardo Reyes, Janell Seeger, Robert A. Somer, Elizabeth Chiu, Gary W. Thomas, Katherine H. R. Tkaczuk, Irfan Vaziri, James L. Wade, M. Wilkinson
Vydáno 2020Artigo -
20
Effect of Primary Tumor Side on Survival Outcomes in Untreated Patients With Metastatic Colorectal Cancer When Selective Internal Radiation Therapy Is Added to Chemotherapy: Combin... Autor Peter Gibbs, Volker Heinemann, Navesh Sharma, Julien Taı̈eb, Jens Ricke, Marc Peeters, Michael Findlay, Bridget A. Robinson, Christopher Jackson, Andrew Strickland, Val Gebski, Mark Van Buskirk, Huaqing Zhao, Guy van Hazel, Michael D. Brown, Matthew Burge, Giuseppe Cardaci, Stephen Clarke, Paul Eliadis, Tom Ferguson, Vinod Ganju, Peter Gibbs, Guy van Hazel, Philip E. James, Christos S. Karapetis, Winston Liauw, Gavin Marx, Marco Matos, Louise Nott, Nick Pavlakis, Alex Powell, Timothy Price, David Ransom, Eva Segelov, Jenny Shannon, Nimit Singhal, Andrew Strickland, Euan Walpole, Michel Craninx, Thierry Delaunoit, Amélie Deleporte, Michel Ferrante, Karen Geboes, Alain Hendlisz, Koen Hendrickx, Marc De Man, Els Monsaert, Veerle Moons, Marc Peeters, Marc Polus, Éveline Boucher, Jacques Balosso, P. Chevallier, Samy Louafi, Marc Pracht, Christine Rebischung, Denis Smith, Julien Taı̈eb, Eric Terrebonne, Harald-Robert Bruch, Gerald Gehbauer, Volker Heinemann, Thomas Helmberger, Yon-Dschun Ko, H. Kröning, Frank Lammert, Arnd Nusch, Stefan Pluntke, Karsten Ridwelski, Jorge Riera‐Knorrenschild, Hanno Riess, Jorge Ramon Riera, Jens Ricke, Tilmann Sauerbruch, Klemens Scheidhauer, Oliver Stötzer, Klaus Tatsch, Ursula Vehling‐Kaiser, Thomas Vogl, Alex Beny, Ravit Geva, Einat Shacham‐Shmueli, Salomon M. Stemmer, Thomas Tichler, Ido Wolf, Bruna Angelelli, Andrea Martoni, Michael Findlay, Richard Isaacs, Anne O’Donnell‐Luria, D Díaz Pérez, Bridget A. Robinson, Javier Rodríguez, Ruth Vera, Pradip Amin, Daniel Bloomgarden, James T. Bui, James Carlisle, Seungjean Chai, Yi‐Jen Chen
Vydáno 2018Artigo
Vyhledávací nástroje:
Související témata
Internal medicine
Medicine
Cancer
Oncology
Prostate cancer
Chemotherapy
Androgen receptor
Biology
Docetaxel
Enzalutamide
Biochemistry
Cancer research
Confidence interval
Hazard ratio
Randomized controlled trial
Urology
Adverse effect
Androgen deprivation therapy
Clinical endpoint
Cohort
Endocrinology
Gene
Metastasis
Physical therapy
Prostate
Surgery
Anesthesia
Bone metastasis
Breast cancer
Colorectal cancer